Shariah compliance overview
HalalTarsus Pharmaceuticals, Inc. (TARS) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions.
Tarsus Pharmaceuticals, Inc. (TARS) operates in the Healthcare sector, in the Biotechnology industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 3.37% (limit 5%), interest-bearing debt is 4.44% (limit 30%) and interest-bearing securities and assets are 22.31% (limit 30%).
If you hold TARS, give 3.37% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 3.37%Limit 5%Pass
- Interest-bearing debt
- 4.44%Limit 30%Pass
- Interest-bearing securities and assets
- 22.31%Limit 30%Pass
- Dividend purification
- 3.37%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Tarsus Pharmaceuticals, Inc. (TARS). Current Akinda screening label: Halal.
